SNOO Smart Sleeper for Infants With CHD

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

May 28, 2022

Study Completion Date

September 12, 2022

Conditions
Congenital Heart DiseaseInfant DevelopmentTechnology
Interventions
DEVICE

SNOO Smart Sleep from Happiest Baby, Inc

Data related to the use of the SNOO itself (collected electronically) such as the amount of movement provided by the SNOO, etc., will be examined with the hemodynamic data obtained during the use of the SNOO. Clinical care data as it relates to the child will also be evaluated as it pertains to the use of the SNOO (this information will focus on the amount and frequency of narcotics administered to the infant). feasibility of use is the device intervention.

Trial Locations (1)

64108

Children's Mercy Kansas City, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT04534335 - SNOO Smart Sleeper for Infants With CHD | Biotech Hunter | Biotech Hunter